Exciting insights into the role of ROR1 in CLL
Can venetoclax be used to treat multiple myeloma (MM)?
EBMT 2016 presentations overview: GvHD and metabolic syndrome
Updates from the CLL14 and CLL2-GiVe trials on CLL
What impact have new minimal residual disease (MRD) assessment techniques had in myeloma?